164 related articles for article (PubMed ID: 3457446)
21. Application of megakaryocytic morphology in diagnosing 5q- syndrome.
Thiede T; Engquist L; Billström R
Eur J Haematol; 1988 Nov; 41(5):434-7. PubMed ID: 3208866
[TBL] [Abstract][Full Text] [Related]
22. Expression of the anti-apoptotic gene survivin in myelodysplastic syndrome.
Badran A; Yoshida A; Wano Y; Mutoh M; Imamura S; Yamashita T; Tsutani H; Inuzuka M; Ueda T
Int J Oncol; 2003 Jan; 22(1):59-64. PubMed ID: 12469185
[TBL] [Abstract][Full Text] [Related]
23. Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome.
Pellagatti A; Cazzola M; Giagounidis A; Perry J; Malcovati L; Della Porta MG; Jädersten M; Killick S; Vyas P; Hellström-Lindberg E; Wainscoat JS; Boultwood J
Br J Haematol; 2011 Oct; 155(2):272-4. PubMed ID: 21492127
[No Abstract] [Full Text] [Related]
24. High incidence of point mutations of p53 suppressor oncogene in patients with myelodysplastic syndrome among atomic-bomb survivors: a 10-year follow-up.
Imamura N; Abe K; Oguma N
Leukemia; 2002 Jan; 16(1):154-6. PubMed ID: 11840277
[No Abstract] [Full Text] [Related]
25. [A case of myelodysplastic syndrome with complex chromosomal defects including 4;11;17 translocation and ring chromosome].
Marase T; Nagai H; Fujiwara Y; Nakaide Y; Tanaka M; Inoue C; Kondo M; Ogura M; Hirota Y
Rinsho Ketsueki; 1987 Jul; 28(7):1175-80. PubMed ID: 3694824
[No Abstract] [Full Text] [Related]
26. Complex chromosomal abnormalities in a patient with refractory anemia with excess blasts (RAEB).
Christodoulidou F; Coleman M; Macera MJ; Verma RS
Cancer Genet Cytogenet; 1991 Jul; 54(2):229-32. PubMed ID: 1884355
[TBL] [Abstract][Full Text] [Related]
27. Philadelphia chromosome positive myelodysplastic syndrome and acute myeloid leukemia-retrospective study and review of literature.
Keung YK; Beaty M; Powell BL; Molnar I; Buss D; Pettenati M
Leuk Res; 2004 Jun; 28(6):579-86. PubMed ID: 15120934
[TBL] [Abstract][Full Text] [Related]
28. Concurrent development of Crohn disease and myelodysplastic syndrome in a child: case report and literature review.
Nahas SC; Nahas CS; Marques CF; Borba MR; Helito AS; Odoni V
Pediatr Hematol Oncol; 2006 Sep; 23(6):477-83. PubMed ID: 16849278
[TBL] [Abstract][Full Text] [Related]
29. 5q- and disordered haematopoiesis.
Bunn HF
Clin Haematol; 1986 Nov; 15(4):1023-35. PubMed ID: 3552346
[No Abstract] [Full Text] [Related]
30. [Myelodysplastic syndromes in two young brothers].
Yabe H; Matsushita A; Ichiba S; Nagai K; Nakayama S
Rinsho Ketsueki; 1992 Feb; 33(2):184-8. PubMed ID: 1635166
[TBL] [Abstract][Full Text] [Related]
31. Primitive hematopoietic stem cells shows a polyclonal pattern in myelodysplastic syndromes.
Guidetti F; Grazioli S; Capelli F; Marini C; Gallicchio M; De Micheli D; Castello L; Sainaghi PP; Fra GP; Saglio G; Avanzi GC
Haematologica; 2004 Jan; 89(1):21-8. PubMed ID: 14754602
[TBL] [Abstract][Full Text] [Related]
32. [Two cases of therapy-related myelodysplastic syndrome].
Takahashi A; Nagoshi H; Yamakawa T; Fukumura R; Matsuoka R; Nomura M; Takahashi S; Isobe H; Ide K; Saito N
Rinsho Ketsueki; 1996 Jan; 37(1):53-9. PubMed ID: 8683868
[TBL] [Abstract][Full Text] [Related]
33. Peripheral blood chromosome aberrations in MDS.
White AD; Jacobs A
Cancer Genet Cytogenet; 1992 Apr; 59(2):167-72. PubMed ID: 1581882
[TBL] [Abstract][Full Text] [Related]
34. [5q anomaly in myelodysplasia and acute myelocytic leukemia].
Robak T
Acta Haematol Pol; 1990; 21(2):235-42. PubMed ID: 2151871
[No Abstract] [Full Text] [Related]
35. A case of atypical myelodysplastic syndrome with a novel reciprocal translocation t(1;12)(q21;p13).
Sánchez J; Serrano J; Román J; García JM; Nomdedéu J; Torres A
Haematologica; 2000 Apr; 85(4):434-5. PubMed ID: 10756375
[No Abstract] [Full Text] [Related]
36. Cytogenetic profile of myelodysplastic syndromes with complex karyotypes: an analysis using spectral karyotyping.
Martínez-Ramírez A; Urioste M; Alvarez S; Vizmanos JL; Calasanz MJ; Cigudosa JC; Benítez J
Cancer Genet Cytogenet; 2004 Aug; 153(1):39-47. PubMed ID: 15325092
[TBL] [Abstract][Full Text] [Related]
37. [Refractory anemia with 5q--anomaly. Clinical picture and follow-up of seven patients].
May D; Becher R
Med Klin (Munich); 1992 Aug; 87(8):408-11. PubMed ID: 1406472
[TBL] [Abstract][Full Text] [Related]
38. 5q-: pathogenetic importance of the common deleted region and clinical consequences of the entire deleted segment.
Pedersen B
Anticancer Res; 1993; 13(5C):1913-6. PubMed ID: 8267400
[TBL] [Abstract][Full Text] [Related]
39. Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?
Lessard M; Hélias C; Struski S; Perrusson N; Uettwiller F; Mozziconacci MJ; Lafage-Pochitaloff M; Dastugue N; Terré C; Brizard F; Cornillet-Lefebvre P; Mugneret F; Barin C; Herry A; Luquet I; Desangles F; Michaux L; Verellen-Dumoulin C; Perrot C; Van den Akker J; Lespinasse J; Eclache V; Berger R;
Cancer Genet Cytogenet; 2007 Jul; 176(1):1-21. PubMed ID: 17574959
[TBL] [Abstract][Full Text] [Related]
40. Antithymocyte globulin and cyclosporine A as combination therapy for low-risk non-sideroblastic myelodysplastic syndromes.
Broliden PA; Dahl IM; Hast R; Johansson B; Juvonen E; Kjeldsen L; Porwit-MacDonald A; Sjoo M; Tangen JM; Uggla B; Oberg G; Hellstrom-Lindberg E
Haematologica; 2006 May; 91(5):667-70. PubMed ID: 16670072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
